The Korean Balm Stick That's Quietly Replacing Tear-Trough Filler in Dublin's Beauty Underground

It started with a screenshot. Then a few more. Within four weeks, three different friends — none of whom knew each other, all of whom had previously sworn by luxury eye creams from La Mer to Charlotte Tilbury — sent us the same product. A small pink Korean balm stick. Same brand. Same active ingredient. Same suspicious price tag of €21.99.

We started asking questions. What we found was a quiet but unmistakable pattern: across Dublin, Cork, Galway and beyond, women between 35 and 50 are abandoning a category they've spent thousands of euro on — and the brands they're walking away from are some of the biggest names in the industry.

The product they're walking toward isn't being heavily marketed. It doesn't have a celebrity face. The brand behind it — Sculpté — has fewer than 4,000 followers on Instagram. And yet, every week, more women are quietly making the switch.

Over the past month, we spoke to twelve customers, two aestheticians, and reviewed twelve clinical papers on the active ingredient at the centre of this. Here's what we learned.

First, the science nobody bothered to tell women

For decades, the beauty industry has marketed eye creams as the solution to under-eye darkness. Caffeine to constrict blood vessels. Retinol to thicken thin skin. Hyaluronic acid to plump. Vitamin K. Vitamin C. The shelves of every Boots in the country are stacked with products promising to "brighten" or "depuff" or "rejuvenate" the under-eye area.

Here is what almost none of them tell you: if you have visible hollows under your eyes — not just dark circles, but actual sunken indents — none of those ingredients can fix it. Hollows are not a pigment problem. They are a structural problem caused by the loss of the small fat pad and collagen cushion that sits beneath the eye. The shadow you see is not a stain. It is light hitting an indent that has formed under the skin.

Until recently, the only solution offered for structural hollows was clinical — injectable filler or polynucleotide treatments delivered directly into the tear-trough area at a starting price of €600 per session. Most clinics recommend a minimum course of three sessions for full effect.

Filler has its own problems. According to the British Association of Aesthetic Plastic Surgeons, somewhere between 12 and 30 percent of tear-trough filler patients experience visible side effects including lumping, migration of the filler away from the injection site, or asymmetry — often months after the original treatment.

It's against this backdrop that PDRN — polynucleotides derived from purified salmon DNA — quietly entered the conversation.

What PDRN actually does

PDRN is not new. Korean dermatology clinics have used it as an injectable since the early 2010s. What is new is the development of low-molecular-weight topical formulations small enough to absorb through the skin barrier without a needle.

At sufficient concentration, topical PDRN appears to do something no eye cream can: stimulate fibroblast activity — the cells responsible for producing new collagen — beneath the surface of the skin. The clinical literature on injectable PDRN is extensive. The literature on topical PDRN is younger but growing rapidly, with early Korean and Italian studies suggesting visible improvement in tear-trough hollowing within 5 days of consistent application.

"If even half of the topical PDRN claims hold, the eye-cream category as we know it is about to look very different."

Which brings us to Sculpté.

The €21.99 product nobody's talking about

Sculpté is a small Irish brand. They have one mission in Ireland — the Hollow Eye Balm — and a modest social presence. They don't run podcast ads. They don't have a celebrity ambassador. According to legible sources, they have sold out twice in 2026 alone.

Their balm contains a clinical-grade concentration of PDRN paired with 5% Volufiline, a patented K-beauty active known for adding visible volume to thinned tissue, and a 200-Dalton collagen complex small enough to absorb topically. The price — €21.99 per stick — works out to roughly 4% of what a single clinical PDRN injection session costs in Dublin.

Who's actually buying it — and why

Over four weeks of interviews, three distinct customer profiles emerged. Each woman came to the product for a different reason. All three reported broadly similar results.

The three women have nothing in common other than the product. Different ages, different professions, different reasons for the hollows. The same balm, the same result, the same timeline.

The numbers, side by side

For women considering tear-trough filler, the financial gap is dramatic — and the medical risk profile is not negligible. The table below summarises the two options most often presented to women with structural under-eye hollows in 2026.

What aestheticians are quietly saying

We spoke to two aestheticians on condition of partial anonymity — one at a high-end Dublin clinic, one at a department-store counter — about topical PDRN and why it has started appearing in their conversations with clients.

Both flagged the same shift: women in their late 30s and 40s are increasingly arriving with a level of skincare research that, even five years ago, would have been unusual outside of dermatologists' offices. They are reading clinical papers. They are asking about molecular weight. They are skeptical of marketing and impatient with products that don't deliver.

Both also agreed on something else — that for hollows that are mild to moderate, topical PDRN is a credible first step. Filler, said the high-end clinician, "is permanent in the wrong way" — meaning that once injected, the result is locked in for six months regardless of whether the patient likes it. Topical alternatives, by contrast, can simply be stopped if they don't deliver.

The cultural moment

It's worth noting why this is happening now. Three forces appear to be converging.

First, the perimenopause conversation. Thanks largely to public figures like Davina McCall, women in Ireland and the UK are now far more aware of perimenopausal collagen loss than they were a decade ago. The drop in estrogen that begins in the mid-40s thins the skin and accelerates the depletion of the under-eye fat pad. Women understand what is happening to their faces, and they want solutions that match that understanding.

Second, the filler backlash. The 2010s celebrated injectable filler as a low-risk, high-reward solution to almost every facial concern. The 2020s have brought a quieter but unmistakable reassessment — partly driven by celebrities openly dissolving their filler, partly by the visible long-term effects of overfilling that are now part of public discourse.

Third, K-beauty's mainstreaming. Korean skincare has gone from niche to canonical in Irish pharmacies in under a decade. With that has come increasing appetite for K-beauty's active ingredients — PDRN, snail mucin, fermented bifida — that lack the household-name recognition of Western actives but are clinically far more interesting.

Where to find it

Sculpté's Hollow Eye Balm is currently available through their direct site, with restocks running approximately every 6 to 8 weeks. The product has sold out twice in 2026.

At time of writing, their Buy 2 Get 2 Free pack — four sticks for €43.99, plus a free collagen mask and eye patches — represents the best value entry point and works out to roughly ten months of supply at twice-daily use. The brand also offers a 30-day money-back guarantee, which several of the women we interviewed cited as the reason they tried it in the first place.

Whether the trend will hold remains to be seen. But based on four weeks of interviews and one quiet Saturday afternoon spent at a Brown Thomas counter watching an aesthetician write the same product name on the back of three different receipts in two hours — it appears to be holding for now.